Correlations of Promoter Methylation in WIF-1, RASSF1A, and CDH13 Genes with the Risk and Prognosis of Esophageal Cancer
Authors:
Open Access
- 10 August 2016
- journal article
- Published by International Scientific Information, Inc. in Medical Science Monitor
- Vol. 22, 2816-2824
Abstract
BACKGROUND:This study was designed to explore the correlations of promoter methylation in Wnt inhibitory factor-1 (WIF-1), ras-association domain family member 1A (RASSF1A), and Cadherin 13 (CDH13) genes with the risk and prognosis of esophageal canc...Keywords
This publication has 30 references indexed in Scilit:
- IRGM Variants and Susceptibility to Inflammatory Bowel Disease in the German PopulationPLOS ONE, 2013
- Methylation of HIN-1, RASSF1A, RIL and CDH13 in breast cancer is associated with clinical characteristics, but only RASSF1A methylation is associated with outcomeBMC Cancer, 2012
- MiR‐142‐3p as a potential prognostic biomarker for esophageal squamous cell carcinomaJournal of Surgical Oncology, 2011
- Hypermethylation-modulated down-regulation of CDH1 expression contributes to the progression of esophageal cancerInternational Journal of Molecular Medicine, 2011
- Hypermethylation-modulated Downregulation of RASSF1A Expression Is Associated with the Progression of Esophageal CancerArchives of Medical Research, 2011
- RASSF1A, APC, ESR1, ABCB1 and HOXC9, but not p16INK4A, DAPK1, PTEN and MT1G genes were frequently methylated in the stage I non-small cell lung cancer in ChinaJournal of Cancer Research and Clinical Oncology, 2009
- Epigenetic alteration of the Wnt inhibitory factor‐1 promoter occurs early in the carcinogenesis of Barrett's esophagusCancer Science, 2007
- Correlation between CpG methylation profiles and hormone receptor status in breast cancersBreast Cancer Research, 2007
- Polymorphisms of the DNA repair gene xeroderma pigmentosum groups A and C and risk of esophageal squamous cell carcinoma in a population of high incidence region of North ChinaJournal of Cancer Research and Clinical Oncology, 2007
- Promoter Methylation and Response to Chemotherapy and Radiation in Esophageal CancerClinical Gastroenterology and Hepatology, 2006